Cover Image
Market Research Report

Global Flow Diversion Aneurysm Treatment Market 2020-2024

Published by TechNavio (Infiniti Research Ltd.) Product code 938060
Published Content info 120 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Flow Diversion Aneurysm Treatment Market 2020-2024
Published: May 14, 2020 Content info: 120 Pages
Description

Technavio has been monitoring the flow diversion aneurysm treatment market and it is poised to grow by $ 1.64 bn during 2020-2024 progressing at a CAGR of 8% during the forecast period. Our reports on flow diversion aneurysm treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the preference for flow diversion aneurysm treatment and increasing prevalence of IAs and associated risk factors. In addition, improvements in the detection of UIAs is anticipated to boost the growth of the market as well.

The flow diversion aneurysm treatment market analysis includes product segment and geographic landscape.

Technavio's ‘flow diversion aneurysm treatment market ’ is segmented as below:

By Product:

  • FDS
  • Intrasaccular flow disruption devices

By Geographic Landscape:

  • North America
  • Europe
  • Asia
  • ROW

This study identifies increasing R&D focus as one of the prime reasons driving the flow diversion aneurysm treatment market growth during the next few years. Also, expanding indications and integration of advanced technologies in aneurysm treatment will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our flow diversion aneurysm treatment market covers the following areas:

  • Flow diversion aneurysm treatment market sizing
  • Flow diversion aneurysm treatment market forecast
  • Flow diversion aneurysm treatment market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading flow diversion aneurysm treatment market vendors that include Acandis GmbH, Boston Scientific Corp., Cardinal Health Inc., Cook Group Inc., Johnson & Johnson, Medtronic Plc, MicroPort Scientific Corp., phenox GmbH, Stryker Corp., and Terumo Corp. Also, the flow diversion aneurysm treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents
Product Code: IRTNTR43691

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product

  • Market segments
  • Comparison by Product
  • FDS - Market size and forecast 2019-2024
  • Intrasaccular flow disruption devices - Market size and forecast 2019-2024
  • Market opportunity by Product

Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Vendor landscape
  • Landscape disruption
  • Competitive scenario

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Acandis GmbH
  • Boston Scientific Corp.
  • Cardinal Health Inc.
  • Cook Group Inc.
  • Johnson & Johnson
  • Medtronic Plc
  • MicroPort Scientific Corp.
  • phenox GmbH
  • Stryker Corp.
  • Terumo Corp.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2019 - 2024 ($ million)
  • 13: Global market: Year-over-year growth 2019 - 2024 (%)
  • 14: Five forces analysis 2019 & 2024
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2019
  • 21: Product - Market share 2019-2024 (%)
  • 22: Comparison by Product
  • 23: FDS - Market size and forecast 2019-2024 ($ million)
  • 24: FDS - Year-over-year growth 2019-2024 (%)
  • 25: Intrasaccular flow disruption devices - Market size and forecast 2019-2024 ($ million)
  • 26: Intrasaccular flow disruption devices - Year-over-year growth 2019-2024 (%)
  • 27: Market opportunity by Product
  • 28: Customer landscape
  • 29: Market share by geography 2019-2024 (%)
  • 30: Geographic comparison
  • 31: North America - Market size and forecast 2019-2024 ($ million)
  • 32: North America - Year-over-year growth 2019-2024 (%)
  • 33: Europe - Market size and forecast 2019-2024 ($ million)
  • 34: Europe - Year-over-year growth 2019-2024 (%)
  • 35: Asia - Market size and forecast 2019-2024 ($ million)
  • 36: Asia - Year-over-year growth 2019-2024 (%)
  • 37: ROW - Market size and forecast 2019-2024 ($ million)
  • 38: ROW - Year-over-year growth 2019-2024 (%)
  • 39: Key leading countries
  • 40: Market opportunity by geography ($ million)
  • 41: Impact of drivers and challenges
  • 42: Vendor landscape
  • 43: Landscape disruption
  • 44: Industry risks
  • 45: Vendors covered
  • 46: Market positioning of vendors
  • 47: Acandis GmbH - Overview
  • 48: Acandis GmbH - Product and service
  • 49: Acandis GmbH - Key offerings
  • 50: Acandis GmbH - Key customers
  • 51: Acandis GmbH - Segment focus
  • 52: Boston Scientific Corp. - Overview
  • 53: Boston Scientific Corp. - Business segments
  • 54: Boston Scientific Corp. - Key offerings
  • 55: Boston Scientific Corp. - Key customers
  • 56: Boston Scientific Corp. - Segment focus
  • 57: Cardinal Health Inc. - Overview
  • 58: Cardinal Health Inc. - Business segments
  • 59: Cardinal Health Inc. - Key offerings
  • 60: Cardinal Health Inc. - Key customers
  • 61: Cardinal Health Inc. - Segment focus
  • 62: Cook Group Inc. - Overview
  • 63: Cook Group Inc. - Product and service
  • 64: Cook Group Inc. - Key offerings
  • 65: Cook Group Inc. - Key customers
  • 66: Cook Group Inc. - Segment focus
  • 67: Johnson & Johnson - Overview
  • 68: Johnson & Johnson - Business segments
  • 69: Johnson & Johnson - Key offerings
  • 70: Johnson & Johnson - Key customers
  • 71: Johnson & Johnson - Segment focus
  • 72: Medtronic Plc - Overview
  • 73: Medtronic Plc - Business segments
  • 74: Medtronic Plc - Key offerings
  • 75: Medtronic Plc - Key customers
  • 76: Medtronic Plc - Segment focus
  • 77: MicroPort Scientific Corp. - Overview
  • 78: MicroPort Scientific Corp. - Business segments
  • 79: MicroPort Scientific Corp. - Key offerings
  • 80: MicroPort Scientific Corp. - Key customers
  • 81: MicroPort Scientific Corp. - Segment focus
  • 82: phenox GmbH - Overview
  • 83: phenox GmbH - Product and service
  • 84: phenox GmbH - Key offerings
  • 85: phenox GmbH - Key customers
  • 86: phenox GmbH - Segment focus
  • 87: Stryker Corp. - Overview
  • 88: Stryker Corp. - Business segments
  • 89: Stryker Corp. - Key offerings
  • 90: Stryker Corp. - Key customers
  • 91: Stryker Corp. - Segment focus
  • 92: Terumo Corp. - Overview
  • 93: Terumo Corp. - Business segments
  • 94: Terumo Corp. - Key offerings
  • 95: Terumo Corp. - Key customers
  • 96: Terumo Corp. - Segment focus
  • 97: Currency conversion rates for US$
  • 98: Research Methodology
  • 99: Validation techniques employed for market sizing
  • 100: Information sources
  • 101: List of abbreviations
Back to Top